Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B5e8663b2db8ac9e329112d0f27ba1c80> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B5e8663b2db8ac9e329112d0f27ba1c80 NCIT_P378 "NCI" @default.
- B5e8663b2db8ac9e329112d0f27ba1c80 type Axiom @default.
- B5e8663b2db8ac9e329112d0f27ba1c80 annotatedProperty IAO_0000115 @default.
- B5e8663b2db8ac9e329112d0f27ba1c80 annotatedSource NCIT_C180584 @default.
- B5e8663b2db8ac9e329112d0f27ba1c80 annotatedTarget "A preparation of autologous T-lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) specific for the tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon administration, anbalcabtagene autoleucel targets and binds to CD19-expressing tumor cells. This results in a cytotoxic T-lymphocyte (CTL) response against CD19-expressing tumor cells and tumor cell lysis. CD19 is a B-cell-specific cell surface antigen overexpressed in B-cell lineage tumors." @default.